Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23169503 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: pegfilgrastim;   Biological: rituximab;   Biological: sargramostim;   Drug: cyclophosphamide;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years